Evidence for a heterogeneous response to erythropoietin in the CFUE pool of human bone marrow

Exp Hematol. 1984 Jan;12(1):31-7.

Abstract

To determine whether the CFUE pool within human bone marrow is heterogeneous with respect to erythropoietin (Epo) requirements, we studied CFUE growth in vitro as a function of Epo exposure time. We controlled the Epo exposure time by overlaying plasma clot cultures containing 0.5 U/ml Epo with an antibody prepared against human Epo. All cultures were grown for seven days. Benzidine-positive colonies containing eight or more cells were counted as CFUE. Colonies containing eight cells required at least 24-50 h of Epo exposure, and those containing 16 cells required at least 70-90 h of Epo exposure. After 50 h, the number of CFUE progressively increased until it reached a maximum at seven days of Epo exposure. These results suggest that the CFUE pool within human bone marrow is heterogeneous with respect to Epo requirements.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Bone Marrow Cells*
  • Child
  • Dose-Response Relationship, Drug
  • Erythroblasts / drug effects*
  • Erythropoietin / pharmacology*
  • Humans
  • Leukemia, Lymphoid / blood
  • Stem Cells / drug effects*
  • Time Factors

Substances

  • Erythropoietin